SOHO Italy 1st School of Multiple Myeloma

 

SOHO Italy 1st School of Multiple Myeloma
L

Combination Therapy in MM: Does Doxorubicin & ENPP1 Inhibitor Combination Improve Anti-Myeloma Innate Immune Response?

By SOHO Italy 1st School of Multiple Myeloma FEATURING Lorenzo Cuollo
By SOHO Italy 1st School of Multiple Myeloma FEATURING Lorenzo Cuollo
15 views
February 3, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
Videos
20:07
SOHO Italy 1st School of Multiple Myeloma

Present Landscape of R/R MM: Post-Bortezomib, Post-Lenalidomide

Feat. C. Cerchione
09:45
SOHO Italy 1st School of Multiple Myeloma

Near-Future Therapy Landscape of R/R MM at Second or Subsequent Rela…

Feat. C. Cerchione
30:19
SOHO Italy 1st School of Multiple Myeloma

[PRIVATE] Present & Near Future of R/R MM: Post-Bortezomib, Post…

Feat. C. Cerchione
13:49
SOHO Italy 1st School of Multiple Myeloma

MM & Extracellular Vesicles: Do MICA+ EVs Impair NKG2D-Mediated …

Feat. E. Vulpis
27:26
SOHO Italy 1st School of Multiple Myeloma

Cell-Adhesion System Targeting in MM: How Does JAM-A Expression Corr…

Feat. A. Solimando
22:20
SOHO Italy 1st School of Multiple Myeloma

Single-Cell Characterization of the BM Immune Microenvironment in MM…

Feat. C. Botta
23:39
SOHO Italy 1st School of Multiple Myeloma

ASCT in MM in Novel Agents Era: Is Long-Term Disease Control and Sur…

Feat. A. Olivieri
16:03
SOHO Italy 1st School of Multiple Myeloma

Primary Plasma Cell Leukemia Peru Experience: How Common Is PCL in M…

Feat. J. Vasquez
19:12
SOHO Italy 1st School of Multiple Myeloma

1st/2nd Relapse in MM: Predictive Factors, EMD, Role of sFLC in MGUS…

Feat. U. Markovic
16:38
SOHO Italy 1st School of Multiple Myeloma

Extracellular Vesicles in Myeloma: What Is Their Role in MGUS-to-MM …

Feat. A. Reale
13:44
SOHO Italy 1st School of Multiple Myeloma

MRD Assessment Within the Bone Marrow of MM: Immunoglobulin Genes as…

Feat. C. Terragna
22:16
SOHO Italy 1st School of Multiple Myeloma

Molecular Pathogenesis of MM: MGUS and SMM, Genomic Complexity of th…

Feat. N. Bolli
18:23
SOHO Italy 1st School of Multiple Myeloma

Bone Marrow Fibroblasts in MM Progression and Tumor Cells Reprogramm…

Feat. I. Saltarella
20:55
SOHO Italy 1st School of Multiple Myeloma

The Myeloma-Specific Tumor Suppressor FAM46C: How Does It Work &…

Feat. E. Milan
08:20
SOHO Italy 1st School of Multiple Myeloma

1L LenDex Combo in Frail MM Patients: How Effective Is It? Is There …

Feat. C. Bellofiore
13:41
SOHO Italy 1st School of Multiple Myeloma

NGS in ALL: Is INO Effective in MRD+ Patients Before HSCT? How Valua…

Feat. G. Martinelli
16:57
SOHO Italy 1st School of Multiple Myeloma

Anti-CD38 in MM Daily Practice: How Can We Potentiate the Action of …

Feat. C. Cerchione
26:05
SOHO Italy 1st School of Multiple Myeloma

Introducing Anti-CD38 in Daily Practice of MM: Updates on the GRIFFI…

Feat. C. Cerchione
19:13
SOHO Italy 1st School of Multiple Myeloma

Daratumumab in MM Daily Practice: Is It Becoming the New Backbone?

Feat. C. Cerchione
10:00
SOHO Italy 1st School of Multiple Myeloma

Bone Marrow CD8+ Tissue-Resident Memory T-Cells in MM: Can the Incre…

Feat. M. Carlisi
13:19
SOHO Italy 1st School of Multiple Myeloma

European Experience in MM: What Are the Potential 1L Options for Tra…

Feat. M. Mateos
10:48
SOHO Italy 1st School of Multiple Myeloma

Exploring Microenvironment of Multiple Myeloma: How Important Is It …

Feat. A. Romano
09:25
SOHO Italy 1st School of Multiple Myeloma

2021 Update Combination Therapies in R/R MM: Which Options Are the M…

Feat. F. Fazio
15:22
SOHO Italy 1st School of Multiple Myeloma

Dissecting Daratumumab Mechanisms of Resistance in MM: Identificatio…

Feat. M. Claudio Da Via
09:34
SOHO Italy 1st School of Multiple Myeloma

Comparison of Different Imaging Techniques in MM: Whole-Body Compute…

Feat. S. Grammatico
10:25
SOHO Italy 1st School of Multiple Myeloma

Combination Therapy in MM: Does Doxorubicin & ENPP1 Inhibitor Co…

Feat. L. Cuollo
11:33
SOHO Italy 1st School of Multiple Myeloma

Allograft in MM: Is There a Role for AlloHSCT & Will Newer Drug …

Feat. F. Vozella
14:02
SOHO Italy 1st School of Multiple Myeloma

2021 Update on R/R MM: Does the Addition of BCNU to Melphalan Improv…

Feat. J. Thomas